<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01484028</url>
  </required_header>
  <id_info>
    <org_study_id>CR-005094</org_study_id>
    <nct_id>NCT01484028</nct_id>
  </id_info>
  <brief_title>Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens</brief_title>
  <official_title>Clinical Validation of Etafilcon A With Print and PVP Contact Lenses for Dark Eyes and Light Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will serve to evaluate and compare the performance of two new lenses to a marketed
      lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Monocular Visual Acuity</measure>
    <time_frame>Dispensing</time_frame>
    <description>Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Fit Acceptance</measure>
    <time_frame>Dispensing</time_frame>
    <description>The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Staining of Grade 3 or 4</measure>
    <time_frame>After 7-9 days of lens wear</time_frame>
    <description>Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade &gt;= 3 were reported.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">275</enrollment>
  <condition>Refractive Ametropia</condition>
  <arm_group>
    <arm_group_label>EALE/1DM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>etafilcon A with PVP for light eyes worn during the first period of 7-9 days then etafilcon A control lens worn during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1DM/EALE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>etafilcon A control lens worn during the first period of 7-9 days then etafilcon A with PVP for light eyes worn during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EADE/1DM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>etafilcon A with PVP for dark eyes worn during the first period of 7-9 days then etafilcon A control lens worn during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1DM/EADE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>etafilcon A control lens worn during the first period of 7-9 days then etafilcon A with PVP for dark eyes worn during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A control lens (1DM)</intervention_name>
    <description>A marketed daily disposable contact lens</description>
    <arm_group_label>EALE/1DM</arm_group_label>
    <arm_group_label>1DM/EALE</arm_group_label>
    <arm_group_label>EADE/1DM</arm_group_label>
    <arm_group_label>1DM/EADE</arm_group_label>
    <other_name>1-DAY ACUVUE MOIST Brand Contact Lenses</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A with print and PVP for light eyes (EALE)</intervention_name>
    <description>A daily disposable contact lens</description>
    <arm_group_label>EALE/1DM</arm_group_label>
    <arm_group_label>1DM/EALE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A with print and PVP for dark eyes (EADE)</intervention_name>
    <description>A daily disposable contact lens</description>
    <arm_group_label>EADE/1DM</arm_group_label>
    <arm_group_label>1DM/EADE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, female adult, at least 18 years of age, and no more than 34 years of age

          -  The subjects must be female, light eye Caucasian, Non-Hispanic, habitual soft contact
             lens wearer (both eyes) with light or dark eyes

          -  Must have rated the Concept Statement positively (i.e., a rating of 4 or 5).

          -  Optimal vertexed spherical equivalent distance correction must be between -1.00 and
             -4.00 diopters (D)

          -  Any cylinder power must be: &lt;=0.75D

          -  Visual acuity must be best correctable to 20/25 or better for each eye

          -  Must have normal eyes (no ocular medications or ocular infection of any type)

          -  Must read and sign the Statement of Informed Consent

          -  Must appear able and willing to adhere to the instructions set forth in this clinical
             protocol.

        Exclusion Criteria:

          -  Ocular or systemic allergies or disease which might interfere with contact lens wear

          -  Systemic disease, autoimmune disease, or use of medication which might interfere with
             contact lens wear

          -  Clinically significant (grade 3 or worse) corneal edema, corneal neovascularization,
             corneal staining, or any other abnormalities of the cornea which would contraindicate
             contact lens wear

          -  Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which
             might interfere with contact lens wear

          -  Any ocular infection

          -  Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear

          -  Any color deficiencies (colorblindness) - to the best of the subject's knowledge

          -  Pregnancy or lactation

          -  Diabetes

          -  Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease
             (e.g. HIV)

          -  Habitual contact lens type is toric, multifocal, or is worn as extended wear.

          -  Subject presents with one dark iris color and one light iris color.

          -  Subject has heterochromia iridis (a difference in color between parts of one iris).

          -  The subject must not be an employee or family member of the clinical study site.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Advanced Optometry</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James R Dugue, Optometrist</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advance Eye Care</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93448</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Vision</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Associates of Winter Park</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Care Associates</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vision Care</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48826</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Eye Care</name>
      <address>
        <city>Jamestown</city>
        <state>New York</state>
        <zip>14702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacco Eye Group</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <zip>13850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Eye Care Group</name>
      <address>
        <city>Grants Pass</city>
        <state>Oregon</state>
        <zip>97526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. David W Ferris and Associates</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02887</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wishnow Sugar Group</name>
      <address>
        <city>Katy</city>
        <state>Texas</state>
        <zip>77450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isthmus Eye Care</name>
      <address>
        <city>Middleton</city>
        <state>Wisconsin</state>
        <zip>53562</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Snowy Range Cision Center</name>
      <address>
        <city>Laramie</city>
        <state>Wyoming</state>
        <zip>82070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>November 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2011</study_first_posted>
  <results_first_submitted>August 30, 2013</results_first_submitted>
  <results_first_submitted_qc>August 30, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 15, 2013</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of those 275 enrolled subjects, 267 subjects were randomized and received the study article in the study. Two subjects were discontinued between the first and second periods.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>1DM/EADE</title>
          <description>etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for dark eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
        </group>
        <group group_id="P2">
          <title>1DM/EALE</title>
          <description>etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for light eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
        </group>
        <group group_id="P3">
          <title>EADE/1DM</title>
          <description>etafilcon A for dark eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
        </group>
        <group group_id="P4">
          <title>EALE/1DM</title>
          <description>etafilcon A for light eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="70"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="67"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="67"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-Compliance to Protocol</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lens Discomfort</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="67"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="67"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline summary was conducted on all randomized subjects who worn at least one pair of study lenses.</population>
      <group_list>
        <group group_id="B1">
          <title>All Subjects</title>
          <description>All randomized subjects who worn at least one pair of study lenses.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="267"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.94" spread="4.654"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Monocular Visual Acuity</title>
        <description>Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.</description>
        <time_frame>Dispensing</time_frame>
        <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>EADE/EALE</title>
            <description>etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.</description>
          </group>
          <group group_id="O2">
            <title>1-DM</title>
            <description>A marketed daily disposable contact lens to correct myopia.</description>
          </group>
        </group_list>
        <measure>
          <title>Monocular Visual Acuity</title>
          <description>Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.</description>
          <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
          <units>LogMAR score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="265"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="528"/>
                <count group_id="O2" value="530"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.044" spread="0.0618"/>
                    <measurement group_id="O2" value="-0.060" spread="0.0589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is the monocular distance Snellen VA (LogMAR scale) of etafilcon A with embedded print and PVP for dark/light eyes is non-inferior to that of etafilcon A control lenses.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A non-inferiority margin of 0.05 LogMAR was used.</non_inferiority_desc>
            <param_type>Least-square mean difference</param_type>
            <param_value>0.011</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.0034</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.004</ci_lower_limit>
            <ci_upper_limit>0.017</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Fit Acceptance</title>
        <description>The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).</description>
        <time_frame>Dispensing</time_frame>
        <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>EADE/EALE</title>
            <description>etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.</description>
          </group>
          <group group_id="O2">
            <title>1-DM</title>
            <description>A marketed daily disposable contact lenses to correct myopia.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Fit Acceptance</title>
          <description>The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).</description>
          <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
          <units>% of Eyes</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="265"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="528"/>
                <count group_id="O2" value="530"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="98.3" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="98.3" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Staining of Grade 3 or 4</title>
        <description>Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade &gt;= 3 were reported.</description>
        <time_frame>After 7-9 days of lens wear</time_frame>
        <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
        <group_list>
          <group group_id="O1">
            <title>EADE/EALE</title>
            <description>etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.</description>
          </group>
          <group group_id="O2">
            <title>1-DM</title>
            <description>A marketed daily disposable contact lenses to correct myopia, two were discontinued between the first and second periods.</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining of Grade 3 or 4</title>
          <description>Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade &gt;= 3 were reported.</description>
          <population>Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.</population>
          <units>% of Eyes</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="528"/>
                <count group_id="O2" value="526"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1.7"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded when the subjects were exposed to the Investigational lenses.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Etafilcon A With PVP for Dark/Light Eyes</title>
          <description>A daily disposable contact lens to correct myopia.</description>
        </group>
        <group group_id="E2">
          <title>Etafilcon A Control Lenses</title>
          <description>A marketed daily disposable contact lens to correct myopia.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="267"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="267"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist</name_or_title>
      <organization>Vistakon, Johnson and Johnson Vision Care</organization>
      <phone>1 904 443 3252</phone>
      <email>mmayers@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

